Question explored with the scientific record
Did the polio vaccine eradicate polio
The polio vaccine did not eradicate polio. It drove wild poliovirus into a few reservoirs while creating a new, ongoing epidemic of vaccine-derived polio.
The story is not simple. The oral polio vaccine (OPV) is a live, weakened virus that can revert to a paralytic form. In the US, vaccine-associated paralytic polio (VAPP) occurred in about 1 in 530,000 first-time vaccinees [1]. The Sabin type 3 strain's key attenuating mutation reverts within days of vaccination [1]. This is not a rare glitch; it is a design feature of a live-virus vaccine.
The evidence shows the vaccine's own success created a trap. As wild poliovirus cases fell, vaccine-derived polioviruses (VDPVs) began causing paralytic outbreaks. A 2006 risk analysis estimated a 50–100% chance of at least one VDPV outbreak in the 20 years after global OPV cessation [5]. By 2020, 26 countries had circulating VDPV (cVDPV) outbreaks [3]. A 2025 study of 3,120 cVDPV2 cases across 75 outbreaks from 2016–2023 found that 92% were seeded by the original Sabin OPV2 strain [6]. The vaccine meant to end polio is now its primary cause of paralysis.
The inactivated polio vaccine (IPV) does not cause VAPP, but it also does not stop transmission as well. In Nigeria and Pakistan, IPV campaigns showed no clear effect on wild poliovirus transmission [2]. The endgame is a choice between a vaccine that causes paralysis and one that may not stop the virus.
| Outcome | OPV (live virus) | IPV (killed virus) |
|---|---|---|
| Causes VAPP | Yes (~1 in 530,000 first doses) [1] | No [4] |
| Seeds cVDPV outbreaks | Yes (92% of 2016–2023 outbreaks) [6] | No |
| Stops fecal-oral transmission | Yes (but creates shed virus) | Weaker than OPV [2] |
| Risk after global cessation | 50–100% chance of outbreak in 20 years [5] | Lower, but not zero |
My call: The polio vaccine dramatically reduced wild poliovirus but did not eradicate it. It created a parallel epidemic of vaccine-derived polio that now causes most new paralytic cases. The eradication campaign traded one disease for another.
Sources used 6
-
Poliovirus vaccination: current understanding of poliovirus interactions in humans and implications for the eradication of poliomyelitis
This narrative review synthesizes understanding of poliovirus pathogenesis, the molecular basis of oral polio vaccine attenuation and reversion, and the implications of vaccine-derived virus for global eradication strategies.
DOI: 10.1017/s1462399499000848 -
Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
Using polio surveillance data from Nigeria and Pakistan (2014–2016), the study estimated the population-level impact of inactivated poliovirus vaccine (IPV) campaigns, finding IPV plus trivalent OPV (IPV+tOPV) campaigns substantially reduced circulating vaccine-derived polioviru…
DOI: 10.3201/eid2302.161210 -
Epidemic poliomyelitis, post-poliomyelitis sequelae and the eradication program
A historical overview of poliomyelitis epidemics, post-polio sequelae, and eradication efforts, detailing vaccine evolution (IPV/OPV), key milestones, and current status including cVDPV outbreaks and nmOPV2 development.
DOI: 10.1071/ma20053 -
Surveillance for Poliovirus Vaccine Adverse Events, 1991 to 1998: Impact of a Sequential Vaccination Schedule of Inactivated Poliovirus Vaccine Followed by Oral Poliovirus Vaccine
In VAERS reports from 1991 to 1998, adverse-event reporting rates, severity profiles, and symptom distributions after IPV were generally similar to OPV in US infants, with no VAPP reported after IPV, supporting the 1999 shift to an all-IPV schedule.
DOI: 10.1542/peds.107.5.e83 -
Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication
A quantitative risk analysis estimates that after polio eradication, continued OPV use causes VAPP and cVDPV outbreaks, while OPV cessation still leaves a 50–100% chance of at least one outbreak in 20 years.
DOI: 10.1111/j.1539-6924.2006.00827.x -
Historical and current spatiotemporal patterns of wild and vaccine-derived poliovirus spread
This Nature Microbiology study analyzes spatiotemporal patterns of 3,120 vaccine-derived poliovirus type 2 (cVDPV2) cases across 75 outbreaks (2016–2023) and 1,572 WPV1 VP1 sequences to quantify transmission dynamics, identify drivers such as population immunity and internationa…
DOI: 10.1038/s41564-025-02174-6